MYCIT Trademark

Trademark Overview


On Monday, July 1, 2019, a trademark application was filed for MYCIT with the United States Patent and Trademark Office. The USPTO has given the MYCIT trademark a serial number of 79267601. The federal status of this trademark filing is REGISTERED as of Tuesday, August 25, 2020. This trademark is owned by BioNTech SE. The MYCIT trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific apparatuses and instruments, namely, next generation sequencers for laboratory research use; software algorithms, namely, downloadable software programs for use in analyzing next generation sequencer data, in particular for the detection and collection of mutations in cancer patients

Pharmaceutical products for the treatment of cancer, in particular based on nucleic acids and/or proteins; personalised patient-specific medicinal products, in particular based on nucleic acids and/or proteins, namely, pharmaceutical preparations for treatment of cancer diseases, autoimmune diseases, and infectious diseases

Medical, veterinary-medical and pharmaceutical advisory services, in particular in the selection of suitable treatments for cancer diseases of all kinds; Medical services, namely, performance of analyses and treatments as part of personalised cancer immunotherapy; Medical services for the treatment of cancer, namely, provision of treatments based on nucleic acids and/or checkpoint inhibitors

High-throughput analytical instruments, in particular instruments for next-generation sequencing (NGS) for medical issues, as well as for gene expression profiling and for the detection of epigenetic changes, namely, high throughput genome and exome gene sequencers for medical use

Medical research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and treatment by means of molecular-biological, genetic, biotechnological and/or bioinformatic methods, in particular by means of next-generation sequencing; Scientific laboratory services and scientific research services featuring diagnostics of tumour markers for personalised treatment
mycit

General Information


Serial Number79267601
Word MarkMYCIT
Filing DateMonday, July 1, 2019
Status700 - REGISTERED
Status DateTuesday, August 25, 2020
Registration Number6132512
Registration DateTuesday, August 25, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2020

Trademark Statements


Goods and ServicesScientific apparatuses and instruments, namely, next generation sequencers for laboratory research use; software algorithms, namely, downloadable software programs for use in analyzing next generation sequencer data, in particular for the detection and collection of mutations in cancer patients
Goods and ServicesPharmaceutical products for the treatment of cancer, in particular based on nucleic acids and/or proteins; personalised patient-specific medicinal products, in particular based on nucleic acids and/or proteins, namely, pharmaceutical preparations for treatment of cancer diseases, autoimmune diseases, and infectious diseases
Goods and ServicesMedical, veterinary-medical and pharmaceutical advisory services, in particular in the selection of suitable treatments for cancer diseases of all kinds; Medical services, namely, performance of analyses and treatments as part of personalised cancer immunotherapy; Medical services for the treatment of cancer, namely, provision of treatments based on nucleic acids and/or checkpoint inhibitors
Goods and ServicesHigh-throughput analytical instruments, in particular instruments for next-generation sequencing (NGS) for medical issues, as well as for gene expression profiling and for the detection of epigenetic changes, namely, high throughput genome and exome gene sequencers for medical use
Goods and ServicesMedical research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and treatment by means of molecular-biological, genetic, biotechnological and/or bioinformatic methods, in particular by means of next-generation sequencing; Scientific laboratory services and scientific research services featuring diagnostics of tumour markers for personalised treatment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioNTech SE
Party Type30 - Original Registrant
Legal Entity Type94 - NOT AVAILABLE
AddressDE

Party NameBioNTech SE
Party Type20 - Owner at Publication
Legal Entity Type94 - NOT AVAILABLE
AddressDE

Party NameBioNTech SE
Party Type10 - Original Applicant
Legal Entity Type94 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Friday, April 15, 2022NEW REPRESENTATIVE AT IB RECEIVED
Saturday, December 19, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 2, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 1, 2020FINAL DISPOSITION PROCESSED
Wednesday, November 25, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 25, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, June 9, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2020PUBLISHED FOR OPPOSITION
Friday, June 5, 2020NOTIFICATION PROCESSED BY IB
Wednesday, May 20, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 20, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 20, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 28, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, March 15, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, March 15, 2020FINAL REFUSAL E-MAILED
Sunday, March 15, 2020FINAL REFUSAL WRITTEN
Friday, February 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, October 26, 2019REFUSAL PROCESSED BY IB
Monday, October 7, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 7, 2019REFUSAL PROCESSED BY MPU
Saturday, September 28, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, September 28, 2019APPLICATION FILING RECEIPT MAILED
Friday, September 27, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 24, 2019ASSIGNED TO EXAMINER
Tuesday, September 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 19, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB